TScan Therapeutics
TCRX
#10917
Rank
C$15.53 M
Marketcap
C$0.23
Share price
-4.40%
Change (1 day)
-83.15%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2026 (TTM): C-$1.27

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is C-$1.30. In 2025 the company made an earnings per share (EPS) of C-$1.43 an increase over its 2024 EPS that were of C-$1.64.

EPS history for TScan Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.27-11.1%
2025C-$1.43-13.04%
2024C-$1.64
2022C-$3.93